- X4 Pharmaceuticals (NASDAQ:XFOR) said it will conduct a one-for-thirty reverse stock split of the company’s common stock.
- The split will reduce the number of shares to ~5.8 million shares from 173.6 million shares.
- The company believes that the split will increase the market price for its common stock and help it meet the minimum bid price requirement.
